About
Full-Life Technologies
Full-Life Technologies Limited ("Full-Life") is a fully integrated global radiotherapeutics company with operations in Belgium, Germany, and China. We aim to own the entire value chain for radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients. The company plans to attack core issues affecting radiopharmaceuticals today through innovative research that targets the treatments of tomorrow.
We are comprised of a team of fast-moving entrepreneurs and scientists with a demonstrated track record in the life sciences, as well as radioisotope research and clinical development.
Team
-
Leadership Team
-
-
Lanny Sun
Co-founder, Chairman & Chief Executive Officer
-
Steffen Heeger, MD, Ph.D.
Chief Medical Officer
-
Fa Liu, Ph.D.
Chief Scientific Officer
-
Hong-hoi Ting, D.Phil.
Co-founder, Board Member & Chief Strategy Officer
-
Philippe van Put
General Manager, Europe
-
Julie Wu
President & Chief Financial Officer
-
Milestones
-
2024. 3
Full-Life’s subsidiary “Full-Life Technology Europe” has obtained a Nuclear Permit for a class IIA facility from the Belgium Federal Agency for Nuclear Control (“FANC”).
2024. 3 -
2024. 1
Full-Life completed $63.3 million financing, comprised of $47.3 million in Series B equity financing and $16 million in loan facilities.
2024. 1 -
2023. 12
Full-Life Technologies Breaks Ground for GMP Manufacturing Facility in Belgium to Advance Its End-to-end Solution for Radiopharmaceuticals.
2023. 12 -
2023. 5
Full-Life Technologies completed land purchase in Belgium to establish GMP manufacturing facility for radiopharmaceutical drug production.
2023. 5 -
2023. 1
Full-Life Technologies Announces Appointment of Chief Medical Officer and Chief Scientific Officer.
2023. 1 -
2022.11
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline.
2022.11 -
2022. 8
Full-Life Technologies Announces Key Leadership Appointments and the Establishment of a Radioisotope Technology Advisory Board.
2022. 8 -
2022. 5
Full-Life Technologies completed $37 million in series A round financing.
2022. 5 -
2022. 1
Full-Life Technologies announced four key appointments to its executive team.
2022. 1 -
2021. 12
Full-Life Technologies completed $10 million in seed round financing.
2021. 12 -
2021. 8
Full-Life Technologies was Founded.
2021. 8